NCT00153140View on ClinicalTrials.gov

Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation

PHASE4CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

October 31, 2004

Conditions
Constipation
Interventions
DRUG

polyethyleneglycol3350

Trial Locations (25)

20707

Laurel

23294

Richmond

23502

Norfolk

23606

Newport News

27103

Winston-Salem

27609

Raleigh

27612

Raleigh

29651

Greer

33461

Lake Worth

33707

St. Petersburg

33770

Largo

36693

Mobile

38120

Memphis

45236

Cincinnati

63017

St Louis

75234

Dallas

76135

Fort Worth

76904

San Angelo

78705

Austin

84121

Salt Lake City

85306

Glendale

92103

San Diego

92801

Anaheim

95825

Sacramento

02135

Brighton

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY